论文部分内容阅读
意大利米兰大学Nicola Principi及其同事在J Med Virol杂志上报告,使用病毒颗粒-胶囊(virosome—encapsulated) 的流感疫苗对接受高活性抗逆转录病毒治疗(HAART)HIV感染患儿是“安全而有适度的免疫原性”。
Nicola Principi and colleagues at the University of Milan, Italy, reported in J Med Virol that using a virosome-encapsulated influenza vaccine was “safe and effective in children with HIV-infected children undergoing high-activity antiretroviral therapy (HAART) Moderate immunogenicity. ”